Biologics CDMO Global Market Report 2025

Global Biologics CDMO Market Report 2024

Biologics CDMO Global Market Report 2025 – By Cell Type (Mammalian, Non-Mammalian), By Product Type (Biologics, Biosimilars) – Market Size, Trends, And Global Forecast 2025-2034

Name: Biologics CDMO Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Biologics CDMO Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Biologics CDMO Global Market Report 2025

Proud Members Of

Biologics CDMO Market Definition

A biologics contract development and manufacturing organization (CDMO) is a service provider that supports pharmaceutical companies in the development and production of biologic drugs, which include vaccines, blood and blood components, allergens, somatic cells, gene therapies, tissues, and recombinant therapeutic proteins.

The main cell types in biologics CDMO are mammalian and non-mammalian. Mammalian refers to cell lines derived from mammals, commonly used in the production of biologics and cell-based therapies due to their ability to produce complex proteins and maintain post-translational modifications. The various products types include biologics and biosimilars.

Biologics CDMO Market Segmentation

The biologics CDMO market covered in this report is segmented –

1) By Cell Type: Mammalian, Non-Mammalian

2) By Product Type: Biologics, Biosimilars

Subsegments:

1) By Mammalian: Chinese Hamster Ovary (CHO) Cells, Human Embryonic Kidney (HEK) Cells, Other Mammalian Cells

2) By Non-Mammalian: Yeast Cells, Bacterial Cells, Insect Cells, Other Non-Mammalian Cells

Biologics CDMO Market Size and growth rate 2025 to 2029: Graph

Biologics CDMO Market Size 2025 And Growth Rate

The biologics CDMO market size has grown rapidly in recent years. It will grow from $21.3 billion in 2024 to $24.37 billion in 2025 at a compound annual growth rate (CAGR) of 14.4%. The growth in the historic period can be attributed to rise in biologics development, cost efficiency and flexibility, focus on core competencies, regulatory compliance and quality assurance, globalization of pharmaceutical supply chains.

Biologics CDMO Market Growth Forecast

The biologics CDMO market size is expected to see rapid growth in the next few years. It will grow to $42.33 billion in 2029 at a compound annual growth rate (CAGR) of 14.8%. The growth in the forecast period can be attributed to increasing demand for biologic therapies, emergence of biosimilars and biobetters, investments in biomanufacturing infrastructure, shift towards outsourcing complex processes, focus on supply chain resilience and risk mitigation, regulatory harmonization, and expedited approvals. Major trends in the forecast period include expansion of capabilities to offer end-to-end solutions, adoption of single-use technologies, integration of continuous manufacturing processes, emergence of specialized CDMOs.

Book your 30 minutes free consultation with our research experts

Biologics CDMO Market Driver: Rise In Demand For Cell And Genetic Therapy Fuels Biologics CDMO Market Growth

The surge in demand for cell and genetic therapy is expected to propel the growth of the biologic CDMO market going forward. Cell and gene therapy are innovative medical approaches that utilize living cells or genetic material to address underlying disease causes at the cellular or genetic level, providing potential treatments for conditions that are difficult to manage or incurable with traditional pharmaceuticals. The demand for cell and gene therapy is rising due to their potential to offer innovative treatments for diseases by addressing underlying genetic or cellular causes. Biologic CDMOs provide expertise in handling living cells, viral vectors, and genetic material, facilitating safe and efficient production of cell and gene therapies while assisting biopharmaceutical companies in navigating regulatory requirements and technical challenges, thereby facilitating translation from research to clinical application. For instance, in January 2023, according to The American Society of Gene & Cell Therapy (ASGCT), a US-based primary professional membership organization, the gene, cell, and RNA therapy pipeline saw 7% growth in 2022, reaching a total of 3,726 therapies in development. Of these, 55% are gene therapies, while 22% are non-genetically modified cell therapies, and 23% are RNA therapies. Therefore, the surge in demand for cell and genetic therapy is driving the growth of the biologic CDMO market.

Global Biologics CDMO Market Major Players

Major companies operating in the biologics CDMO market are AbbVie Inc., Thermo Fisher Scientific Inc., Novartis AG, Evonik Industries AG, Sandoz International GmbH, ICON PLC, Grifols SA, Lonza Group Ltd., Boehringer Ingelheim International GmbH, Catalent Inc., JSR Corp., Parexel International Corporation, WuXi Biologics (Cayman) Inc., Samsung Biologics Co. Ltd., Emergent BioSolutions Inc., Rentschler Biopharma SE, FUJIFILM Diosynth Biotechnologies U.S.A. Inc., Binex Co. Ltd., Bora Pharmaceuticals Co. Ltd, 3P Biopharmaceuticals s.l.u, JRS Pharma LP, J Rettenmaier and SOHNE GmbH and Co KG, Kemwell Biopharma Pvt. Ltd., Cytovance Biologics, AGC Biologics, Shenzhen Hepalink Pharmaceutical Co. Ltd.

Global Biologics CDMO Market Trend: Advancements In Biologics CDMO

Major companies operating in the biologics CDMO market are developing technologically advanced solutions, such as new cell lines, to enhance biopharmaceutical development and manufacturing efficiency and capabilities. The technology produces therapeutic antibodies with enhanced potency, addressing immunotherapy research and development challenges. For instance, in November 2023, Lonza Group, a Switzerland-based manufacturing company that specializes in the pharmaceutical and biotechnology sectors, launched GS Effex cell lines, designed to produce antibodies that are 100% free of fucose, a sugar molecule and demonstrate increased potency without compromising on other performance attributes. It helps overcome immunotherapy research and development challenges related to the need for antibody therapeutics to increase potency. It is a stable, scalable, and productive cell line that provides a solution for therapeutic development from discovery-stage research through commercial manufacturing.

Biologics CDMO Market Merger And Acquisition: Bora Pharmaceuticals Expands Global Footprint With Acquisition Of Eden Biologics Inc.

In May 2022, Bora Pharmaceuticals Co. Ltd., a Taiwan-based organization that specializes in manufacturing and selling pharmaceutical products, acquired the CDMO assets of Eden Biologics Inc. for $100 million. The acquisition aims to expand its presence in the global CDMO market, particularly focusing on biologics, macromolecules, and cell and gene therapy markets. Eden Biologics Inc. is a Taiwan-based biotechnology company specializing in the contract development and manufacturing of innovative biologics for therapeutic applications.

Regional Outlook For The Global Biologics CDMO Market

North America was the largest region in the biologics CDMO market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biologics CDMO market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the biologics CDMO market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Biologics CDMO Market?

The biologics CDMO market consist of revenues earned by entities by providing services such as process development, analytical development, cell line development, supply chain management, and fill-finish services. The biologics CDMO market also includes sales of monoclonal antibodies, recombinant proteins, antisense and molecular therapy, and vaccines. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Biologics CDMO Industry?

The biologics CDMO research report is one of a series of new reports from The Business Research Company that provides biologics CDMO market statistics, including the biologics CDMO industry's global market size, regional shares, competitors with an biologics CDMO market share, detailed biologics CDMO market segments, market trends and opportunities, and any further data you may need to thrive in the biologics CDMO industry. This biologics CDMO market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Biologics CDMO Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$24.37 billion
Revenue Forecast In 2034	$42.33 billion
Growth Rate	CAGR of 14.8% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Cell Type: Mammalian, Non-Mammalian 2) By Product Type: Biologics, Biosimilars Subsegments: 1) By Mammalian: Chinese Hamster Ovary (CHO) Cells, Human Embryonic Kidney (HEK) Cells, Other Mammalian Cells 2) By Non-Mammalian: Yeast Cells, Bacterial Cells, Insect Cells, Other Non-Mammalian Cells
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	AbbVie Inc., Thermo Fisher Scientific Inc., Novartis AG, Evonik Industries AG, Sandoz International GmbH, ICON PLC, Grifols SA, Lonza Group Ltd., Boehringer Ingelheim International GmbH, Catalent Inc., JSR Corp., Parexel International Corporation, WuXi Biologics (Cayman) Inc., Samsung Biologics Co. Ltd., Emergent BioSolutions Inc., Rentschler Biopharma SE, FUJIFILM Diosynth Biotechnologies U.S.A. Inc., Binex Co. Ltd., Bora Pharmaceuticals Co. Ltd, 3P Biopharmaceuticals s.l.u, JRS Pharma LP, J Rettenmaier and SOHNE GmbH and Co KG, Kemwell Biopharma Pvt. Ltd., Cytovance Biologics, AGC Biologics, Shenzhen Hepalink Pharmaceutical Co. Ltd.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Biologics CDMO Market Characteristics

3. Biologics CDMO Market Trends And Strategies

4. Biologics CDMO Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Biologics CDMO Growth Analysis And Strategic Analysis Framework

5.1. Global Biologics CDMO PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Biologics CDMO Market Growth Rate Analysis

5.4. Global Biologics CDMO Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Biologics CDMO Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Biologics CDMO Total Addressable Market (TAM)

6. Biologics CDMO Market Segmentation

6.1. Global Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Mammalian

Non-Mammalian

6.2. Global Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Biologics

Biosimilars

6.3. Global Biologics CDMO Market, Sub-Segmentation Of Mammalian, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Chinese Hamster Ovary (CHO) Cells

Human Embryonic Kidney (HEK) Cells

Other Mammalian Cells

6.4. Global Biologics CDMO Market, Sub-Segmentation Of Non-Mammalian, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Yeast Cells

Bacterial Cells

Insect Cells

Other Non-Mammalian Cells

7. Biologics CDMO Market Regional And Country Analysis

7.1. Global Biologics CDMO Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Biologics CDMO Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Biologics CDMO Market

8.1. Asia-Pacific Biologics CDMO Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Biologics CDMO Market

9.1. China Biologics CDMO Market Overview

9.2. China Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Biologics CDMO Market

10.1. India Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Biologics CDMO Market

11.1. Japan Biologics CDMO Market Overview

11.2. Japan Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Biologics CDMO Market

12.1. Australia Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Biologics CDMO Market

13.1. Indonesia Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Biologics CDMO Market

14.1. South Korea Biologics CDMO Market Overview

14.2. South Korea Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Biologics CDMO Market

15.1. Western Europe Biologics CDMO Market Overview

15.2. Western Europe Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Biologics CDMO Market

16.1. UK Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Biologics CDMO Market

17.1. Germany Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Biologics CDMO Market

18.1. France Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Biologics CDMO Market

19.1. Italy Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Biologics CDMO Market

20.1. Spain Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Biologics CDMO Market

21.1. Eastern Europe Biologics CDMO Market Overview

21.2. Eastern Europe Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Biologics CDMO Market

22.1. Russia Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Biologics CDMO Market

23.1. North America Biologics CDMO Market Overview

23.2. North America Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Biologics CDMO Market

24.1. USA Biologics CDMO Market Overview

24.2. USA Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Biologics CDMO Market

25.1. Canada Biologics CDMO Market Overview

25.2. Canada Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Biologics CDMO Market

26.1. South America Biologics CDMO Market Overview

26.2. South America Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Biologics CDMO Market

27.1. Brazil Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Biologics CDMO Market

28.1. Middle East Biologics CDMO Market Overview

28.2. Middle East Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Biologics CDMO Market

29.1. Africa Biologics CDMO Market Overview

29.2. Africa Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Biologics CDMO Market Competitive Landscape And Company Profiles

30.1. Biologics CDMO Market Competitive Landscape

30.2. Biologics CDMO Market Company Profiles

30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Evonik Industries AG Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Sandoz International GmbH Overview, Products and Services, Strategy and Financial Analysis

31. Biologics CDMO Market Other Major And Innovative Companies

31.1. ICON PLC

31.2. Grifols SA

31.3. Lonza Group Ltd.

31.4. Boehringer Ingelheim International GmbH

31.5. Catalent Inc.

31.6. JSR Corp.

31.7. Parexel International Corporation

31.8. WuXi Biologics (Cayman) Inc.

31.9. Samsung Biologics Co. Ltd.

31.10. Emergent BioSolutions Inc.

31.11. Rentschler Biopharma SE

31.12. FUJIFILM Diosynth Biotechnologies U.S.A. Inc.

31.13. Binex Co. Ltd.

31.14. Bora Pharmaceuticals Co. Ltd

31.15. 3P Biopharmaceuticals s.l.u

32. Global Biologics CDMO Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biologics CDMO Market

34. Recent Developments In The Biologics CDMO Market

35. Biologics CDMO Market High Potential Countries, Segments and Strategies

35.1 Biologics CDMO Market In 2029 - Countries Offering Most New Opportunities

35.2 Biologics CDMO Market In 2029 - Segments Offering Most New Opportunities

35.3 Biologics CDMO Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Biologics CDMO Market, Sub-Segmentation Of Mammalian, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Biologics CDMO Market, Sub-Segmentation Of Non-Mammalian, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Biologics CDMO Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Biologics CDMO Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Asia-Pacific, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Asia-Pacific, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: China, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: China, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: India, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: India, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Japan, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Japan, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: Australia, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: Australia, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: Indonesia, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Indonesia, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: South Korea, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: South Korea, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Western Europe, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Western Europe, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: UK, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: UK, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Germany, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Germany, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: France, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: France, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Italy, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Italy, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Spain, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Spain, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Eastern Europe, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Eastern Europe, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Russia, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Russia, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: North America, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: North America, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: USA, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: USA, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Canada, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Canada, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: South America, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: South America, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Brazil, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Brazil, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Middle East, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Middle East, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Africa, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Africa, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: AbbVie Inc. Financial Performance

Table 54: Thermo Fisher Scientific Inc. Financial Performance

Table 55: Novartis AG Financial Performance

Table 56: Evonik Industries AG Financial Performance

Table 57: Sandoz International GmbH Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Biologics CDMO Market, Sub-Segmentation Of Mammalian, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Biologics CDMO Market, Sub-Segmentation Of Non-Mammalian, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Biologics CDMO Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Biologics CDMO Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Asia-Pacific, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Asia-Pacific, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: China, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: China, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: India, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: India, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Japan, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Japan, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: Australia, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: Australia, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: Indonesia, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Indonesia, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: South Korea, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: South Korea, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Western Europe, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Western Europe, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: UK, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: UK, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Germany, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Germany, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: France, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: France, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Italy, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Italy, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Spain, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Spain, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Eastern Europe, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Eastern Europe, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Russia, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Russia, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: North America, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: North America, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: USA, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: USA, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Canada, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Canada, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: South America, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: South America, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Brazil, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Brazil, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Middle East, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Middle East, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Africa, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Africa, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: AbbVie Inc. Financial Performance

Figure 54: Thermo Fisher Scientific Inc. Financial Performance

Figure 55: Novartis AG Financial Performance

Figure 56: Evonik Industries AG Financial Performance

Figure 57: Sandoz International GmbH Financial Performance

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

The Microbiome Market Share, Market Size, And Growth Rate 2022

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the kidney cancer drugs market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the cancer MAbs market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the precision medicine market research report 2022 with industry size, share, segments and market growth

Biodegradable Plastics Global Market Report 2025 – By Type (Polylactic Acid (PLA), Polybutylene Adipate Terephthalate (PBAT), Polybutylene Succinate (PBS), PHA (Polyhydroxyalkanoates), Starch Blends, Other Types), By End User (Packaging, Agriculture, Consumer Goods, Others) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Soap And Other Detergents Global Market Report 2025 – By Product Type (Laundry Detergent, Soap, Dishwashing Detergent, Toothpaste, Other Product Types), By Application (Homecare Detergents, Industrial Soap and Detergent, Homecare Soaps, Other Applications), By End User (Body, Clothing, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Detergent Chemicals Global Market Report 2025 – By Product( Surfactants, Builders And Fillers, Enzymes, Fragrances, Bleaching Agents), By Form( Solid Detergents, Liquid Detergents), By Application( Laundry Cleaning Products, Household And Commercial Cleaning Products, Personal Cleaning Products, Dishwashing Products, Fuel Additives, Biological Reagents) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Biometric Payment Global Market Report 2025 – By Type (Contact-Based, Contactless, Hybrid), By Component (Hardware, Software, Services), By Technology (Single Factor Authentication, Fingerprint Recognition, Iris Recognition, Palm Recognition, Face Recognition, Signature Recognition, Voice Recognition, Biometric Smart Card, Multimodal), By Mode Of Payment (Smartphone And Tablet, Biometric And Smart Cards, Other Modes), By Application (Banking, Financial Services And Insurance (BFSI), Retail And Ecommerce, Travel And Hospitality, Transportation, Healthcare, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Wood Bio-Products Global Market Report 2025 – By Product Type (Biofuels, Bioplastics, Biochemicals, Biocomposites, Pulp And Papers), By Distribution Channel (Offline, Online), By Application (Energy, Packaging, Construction, Automotive, Chemicals), By End Use Industry (Residential, Commercial, Industrial, Infrastructure, Other End Use Industries) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Biometrics-As-A-Service Global Market Report 2025 – By Scanner Type (Fingerprint Recognition, Iris Recognition, Palm Recognition, Facial Recognition, Voice Recognition, Other Scanner Types), By Modality (Unimodal, Multimodal), By Deployment Model (Public Cloud, Private Cloud, Hybrid Cloud), By Application (Site Access Control, Time Recording, Mobile Application, Web And Workplace), By End-User (Government, Retail, IT (Information Technology) And Telecom, Banking, Financial Services And Insurance (BFSI), Healthcare, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Biodegradable Films Global Market Report 2025 – By Type (Polylactic Acid (PLA), Starch Blends, Biodegradable Polyesters, Polyhydroxyalkanoates (PHA), Other Types), By Application (Bags, Mulch Films, Wrapping Films, Liners, Other Applications), By End-Use (Food And Beverage, Healthcare, Personal Care And Cosmetics, Agriculture, Metal, Glass, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Biodegradable Paper and Plastic Packaging Global Market Report 2025 – By Type (Starch Based Plastic, Cellulose Based Plastic, Polylactic Acid (PLA), Polyhydroxyalkanoates (PHA), Other Types), By Material (Paper, Plastic), By Application (Beverage Packaging, Personal And Home Care Packaging, Electronic Appliance Packaging, Food Packaging, Pharmaceutical Packaging, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Biologics CDMO market?

How will the Biologics CDMO market drivers and restraints affect the market dynamics? What forces will shape the Biologics CDMO industry going forward?

The Biologics CDMO market major growth driver - Rise In Demand For Cell And Genetic Therapy Fuels Biologics CDMO Market Growth. For further insights on the Biologics CDMO market, request a sample here

What is the forecast market size or the forecast market value of the Biologics CDMO market?

The Biologics CDMO market size has grown strongly in recent years. The biologics cdmo market size has grown rapidly in recent years. It will grow from $21.3 billion in 2024 to $24.37 billion in 2025 at a compound annual growth rate (CAGR) of 14.4%. The growth in the historic period can be attributed to rise in biologics development, cost efficiency and flexibility, focus on core competencies, regulatory compliance and quality assurance, globalization of pharmaceutical supply chains. The biologics cdmo market size is expected to see rapid growth in the next few years. It will grow to $42.33 billion in 2029 at a compound annual growth rate (CAGR) of 14.8%. The growth in the forecast period can be attributed to increasing demand for biologic therapies, emergence of biosimilars and biobetters, investments in biomanufacturing infrastructure, shift towards outsourcing complex processes, focus on supply chain resilience and risk mitigation, regulatory harmonization, and expedited approvals. Major trends in the forecast period include expansion of capabilities to offer end-to-end solutions, adoption of single-use technologies, integration of continuous manufacturing processes, emergence of specialized CDMOs. For further insights on the Biologics CDMO market, request a sample here

How is the Biologics CDMO market segmented?

The biologics cdmo market covered in this report is segmented –
1) By Cell Type: Mammalian, Non-Mammalian
2) By Product Type: Biologics, Biosimilars Subsegments:
1) By Mammalian: Chinese Hamster Ovary (CHO) Cells, Human Embryonic Kidney (HEK) Cells, Other Mammalian Cells
2) By Non-Mammalian: Yeast Cells, Bacterial Cells, Insect Cells, Other Non-Mammalian Cells For further insights on the Biologics CDMO market, request a sample here

Which region has the largest share of the Biologics CDMO market? What are the other regions covered in the report?

North America was the largest region in the biologics CDMO market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biologics CDMO market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Biologics CDMO market, request a sample here.

Who are the major players in the Biologics CDMO market?

What are the key trends in the Biologics CDMO market?

Major trends in the Biologics CDMO market include Advancements In Biologics CDMO. For further insights on the Biologics CDMO market, request a sample here.

What are the major opportunities in the Biologics CDMO market? What are the strategies for the Biologics CDMO market?

For detailed insights on the major opportunities and strategies in the Biologics CDMO market, request a sample here.

How does the Biologics CDMO market relate to the overall economy and other similar markets?

For detailed insights on Biologics CDMO's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Biologics CDMO industry?

For detailed insights on the mergers and acquisitions in the Biologics CDMO industry, request a sample here.

What are the key dynamics influencing the Biologics CDMO market growth? SWOT analysis of the Biologics CDMO market.

For detailed insights on the key dynamics influencing the Biologics CDMO market growth and SWOT analysis of the Biologics CDMO industry, request a sample here.